| 注册
首页|期刊导航|中国临床药理学杂志|细胞色素CYP3A4 * 1G基因多态性与肾移植患者术后发生钙调神经蛋白抑制剂慢性肾毒性的相关性

细胞色素CYP3A4 * 1G基因多态性与肾移植患者术后发生钙调神经蛋白抑制剂慢性肾毒性的相关性

保泽庆 赵树进 朱云松 石磊

中国临床药理学杂志2017,Vol.33Issue(5):401-403,3.
中国临床药理学杂志2017,Vol.33Issue(5):401-403,3.DOI:10.13699/j.cnki.1001-6821.2017.05.005

细胞色素CYP3A4 * 1G基因多态性与肾移植患者术后发生钙调神经蛋白抑制剂慢性肾毒性的相关性

Correlation between calcineurin inhibitor drug-induced chronic nephrotoxicity in patient after kidney allograft and the CYP3A4 * 1G gene polymorphism

保泽庆 1赵树进 2朱云松 2石磊2

作者信息

  • 1. 肇庆医学高等专科学校药理教研室,广东肇庆526020
  • 2. 解放军广州军区广州总医院药学部,广州510010
  • 折叠

摘要

Abstract

Objective To observe the relationship between CYP3A4 * 1G genetic polymorphism with calcineurin inhibitor(CNI)-induced chronic nphrotoxicity in Chinese population.Methods Blood samples and clinical data were collected from 200 Chinese patients with CNI drug-induced chronic nephrotoxicity as treatment group and 200 Chinese kidney allograft recipients without chronic nephrotoxicity as the control.DNA was extracted from the blood samples of patients in two groups,and the frequencies of CYP3A4 * 1G genotypes were analyzed using polymerase chain reaction-restriction fragment length polymorphism.The relationship between the polymorphisms of CYP3A4 * 1G and the CNI drug-induced chronic nephrotoxicity was analyzed.Results The frequencies of the 3 gene types CYP3A4 * 1G RsaI 1/1,1/1G,and 1G/1G were 51% (102/200),34.5% (69/200) and 14.5% (29/200) respectively in patients with CNI drug-induced chronic nephrotoxicity (treatment group),and49.5% (99/200),45% (90/200),and5.5% (11/200) respectively in the control group.A statistical difference was found between the cases and the control (P < 0.05,OR =2.914,95% CI =1.41-6.01).Conclusion The polymorphism of CYP3A4 * 1 G/* 1G remained a significant independent risk factor for CNIs drug-induced chronic nephrotoxicity after kidney allograft.

关键词

慢性肾毒性/钙调神经蛋白抑制剂/CYP3A4 * 1G/基因多态性

Key words

chronic nephrotoxicity/calcineulin inhibitor/cytochrome P4503A4 * 1G/polymorphism

分类

医药卫生

引用本文复制引用

保泽庆,赵树进,朱云松,石磊..细胞色素CYP3A4 * 1G基因多态性与肾移植患者术后发生钙调神经蛋白抑制剂慢性肾毒性的相关性[J].中国临床药理学杂志,2017,33(5):401-403,3.

基金项目

广东省科技计划项目社会发展计划基金资助项目(2005B30701004) (2005B30701004)

广东省自然科学基金资助项目(8151001002000006 ()

S201301001195) ()

广州市重点实验室基金资助项目(201509010012) (201509010012)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文